ABVC Biopharma Inc (ABVC) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Over the past 4 years, ABVC Biopharma Inc has achieved a revenue compound annual growth rate (CAGR) of 1.3%, while earnings have grown at -16.1% CAGR.
Historical revenue and profitability trends for ABVC Biopharma Inc
The chart above illustrates ABVC Biopharma Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of ABVC Biopharma Inc's business.
How efficiently ABVC Biopharma Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue ABVC Biopharma Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project ABVC Biopharma Inc to continue focusing on sustainable operations. The consensus analyst rating is 3 based on 1 analyst.
Based on our comprehensive analysis, ABVC Biopharma Inc (ABVC) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of ABVC Biopharma Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how ABVC Biopharma Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: ABVC Valuation, ABVC Dividend, ABVC Financial Health
Compare: ABVC vs AAPL, ABVC vs MSFT, ABVC vs GOOGL